Clinical significance of cardiovascular dysmetabolic syndrome (Q24794239)

Current controlled trials in cardiovascular medicine

Europe PubMed Central

title

Clinical significance of cardiovascular dysmetabolic syndrome (English)

0 references

1 reference

Prakash C Deedwania

1

0 references

publication date

7 January 2002

0 references

published in

1 reference

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

PubMed

volume

3

0 references

issue

1

0 references

page(s)

2

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Diabetic and hypertensive heart disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Hyperglycemia and microvascular and macrovascular disease in diabetes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Banting lecture 1988. Role of insulin resistance in human disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Insulin Resistance, Hyperinsulinemia, and Coronary Artery Disease: A Complex Metabolic Web

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Metformin Associated Lactic Acidosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

The deadly quartet revisited.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

The impact of cardiovascular disease on people with diabetes: the potential for prevention

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=134474

Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1468-6708-3-2

Cardiovascular risk continuum: implications of insulin resistance and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1468-6708-3-2

The cardiovascular dysmetabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1468-6708-3-2

The new diagnostic criteria for diabetes: the impact on management of diabetes and macrovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1468-6708-3-2

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1468-6708-3-2

Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1468-6708-3-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1468-6708-3-2